The osteoclast is vital for establishment of normal hematopoiesis in the developing animal.
Introduction
The osteoclast responsible for the resorption of bone and the osteoblast ensuring formation of new bone are two unique cell types that continuously repair and maintain the human skeleton through a tightly coordinated process known as bone remodeling. During ontogeny, both osteoclasts and osteoblasts are essential for the formation of the specialized microenvironmental niche where the blood forming hematopoietic stem cells reside, the hematopoietic niche 1, 2 . The hematopoietic stem cells (HSCs) interaction with their microenvironment is critical when maintaining normal hematopoiesis and their specific fate is determined through complex, bidirectional interactions with various cell types and stromal cell components [3] [4] [5] . In the adult bone marrow (BM), different stromal cells regulate HSCs.
Osteoblasts maintain the HSCs in an undifferentiated, quiescent state by providing inhibitory signals like Jagged and Angiopoietin 1, but also by expressing N-cadherin and VCAM that interact with integrins expressed on HSCs, attaching them to the niche [6] [7] [8] [9] [10] [11] . Vascular stromal cells e.g. sinusoidal endothelial cells 12 , fibroblast-like reticular cells and Nestin+ mesenchymal stem cells that express high levels of SDF-1/CXCL12 also play key roles in HSC maintenance [13] [14] [15] [16] [17] .
Lately, several reports have highlighted the importance of the osteoclast in regulation of the hematopoietic niche, but its precise role for this process under various conditions still remains controversial. It has been shown that osteoclast mediated-resorption promotes mobilization of HSCs and progenitors from the niche to the circulation by cathepsin K-mediated cleavage of CXCL12 18 . In contrast to this, osteoclast inhibition was also shown to increase mobilization 19, 20 .
In addition it has been demonstrated that mice lacking calcium-sensing receptors have reduced numbers of HSCs in the BM, indicating that the calcium released as a consequence of bone resorption, is important for the correct localization of HSCs and that this is specified by calcium-sensing receptors 21, 22 . Furthermore, when normal mice were treated with the bisphosphonate alendronate, that inhibits and induces apoptosis in osteoclasts, a slight reduction of HSCs in the BM was observed 23 .
In the present study, aiming to explore the role of the osteoclast for maintenance of adult hematopoiesis, two osteopetrotic mouse models were used, the oc/oc and RANK KO. Oc/oc mice with a mutation in the Tcirg1 gene lack osteoclastic V-ATPase activity and have completely abolished resorptive function, but a high amount of osteoclasts and a severe osteopetrotic phenotype with a short life expectancy of 3-4 weeks 24 . In contrast, the RANK KO mouse is defective in osteoclast differentiation and is therefore devoid of osteoclasts.
Both models suffer from osteopetrosis, but the phenotype is less severe and the life expectancy is longer in the RANK KO than in the oc/oc mouse 25 . By irradiating wild type mice and subsequently transplanting fetal liver cells from either oc/oc or RANK KO mice, we generated adult mice with osteopetrosis suited for studying the role of osteoclasts for maintenance of hematopoiesis in this setting. . All experiments were performed according to protocols approved by the local animal ethics committee (number 333-11).
Methods

Mice
Genotyping of mice
Mice were genotyped by PCR of tail tips, as described previously 27 .
Fetal liver cell harvesting
Fetal liver cells were collected as described previously
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.
Primary transplantations
Three-month old B6SJL (CD45.1) recipients were transplanted with two million freshly thawed FL cells (CD45.2) administered by tail vein injection after lethal irradiation (950 cGy). Post transplant mice were treated with ciprofloxacin. 
Secondary transplantations
Cell cycle analysis
For the cell cycle analysis of BM, antibodies were directed against lineage-positive cells (CD4, CD5, GR1, Lyt2, Ter119, CD11b and CD45R/b220)-PeCy5, c-kit-APC780, Sca1-APC, CD48-FITC, CD150-PeCy7, Ki67-PE and DAPI-Pacific Blue. For the analysis of FL cells the lineage cocktail was (CD3, Ter119, B220, Gr1)-PECy5 (Becton Dickinson) (suppl Methods).
Colony-forming unit cell (CFU-C) assay
Freshly isolated BM cells (20000 cells) were plated in duplicate in 35 mm dishes in 1.5 ml of
Complete Methocult Media (Stem Cell Technologies). Colonies were counted on day 12.
Micro Computed Tomography (µCT)
The cortical and trabecular femoral bone architecture was evaluated using a high resolution µCT scanner (µCT 35; Scanco Medical AG, Brüttisellen, Switzerland) (suppl Mat & Meth).
Cortical bone volume fraction BV/TV and cortical thickness Ct.Th* were calculated using the software provided with the scanner (IPL, version 5.15). The asterisk denotes that the cortical thickness was computed with the direct method, i.e. without model assumptions 29 .
Splenocyte osteoclast differentiation and resorption
Splenocytes were isolated as previously described 30 and were differentiated into mature osteoclasts (suppl Meth). Resorption pits were visualized by staining with Mayer's Hematoxylin. The resorbed area was measured using NewCAST software (Visiopharm, Hørsholm, Denmark) with an Olympus IX-70 microscope (Olympus, Center Valley, PA).
TRAP staining of osteoclasts
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Fixed osteoclasts in cell culture were stained using the Leukocyte TRAP staining kit (SigmaAldrich). Histological sections of bone were stained for TRAP, counterstained with Mayer's Hematoxylin and mounted with DPX.
Biomarkers
TRAP5b and CTX-I were measured in serum using mouse TRAP5b ELISA kit and RatLaps ELISA kit (Immunodiagnostics systems) respectively, according to standard protocols.
Statistical analysis
Statistical analysis was performed either with unpaired two-sided Student's t-test, 1-way In vivo assessment of osteoclast numbers confirmed the osteoclast-rich and -poor phenotypes, as TRAP5b (a biomarker of osteoclasts), was markedly increased in the serum of the oc/oc recipient group and significantly reduced in the serum of the RANK KO recipient group (Table 1) . With respect to bone resorption the levels of the bone resorption marker CTX-1 was significantly reduced in the serum of mice from both experimental groups when compared to the control recipients (Table 1) .
To assess the bone phenotype of the two groups of transplanted mice, cortical BV/TV and cortical thickness were assessed at the femoral midshaft, and as shown there was a significant increase in both parameters in both the oc/oc and the RANK KO recipient groups when compared to the control recipients (Table 1) . Furthermore, the magnitude of the increase was similar in the two groups, comparing well to a previous study using the oc/oc recipient model 28 .
In summary, a mild osteopetrotic phenotype was observed in both the oc/oc recipient and the RANK KO recipient group; however, the former was osteoclast-rich and the latter was osteoclast-poor. Further analysis confirming the osteopetrotic phenotype in both these models has been performed (Thudium et al., manuscript in preparation).
BM cellularity is unaffected in both oc/oc and RANK KO recipients while progenitor cell number is slightly reduced in RANK KO recipients but unchanged in oc/oc recipients.
When BM cellularity was evaluated by counting the total number of cells in one femur per recipient mouse sacrificed after 15 weeks, no difference was found between oc/oc, RANK KO and control recipients ( Figure 2a ). When the level of progenitor cells was assessed by CFUformation no difference was found between oc/oc and control recipients whereas a slight reduction was seen in the RANK KO recipients as compared to control recipients ( Figure 2b ). 
Discussion
The HSC niche is a complex environment involving many different regulators. One key regulator is the osteoblast but recent findings have also highlighted the essential roles of endothelial and perivascular mesenchymal progenitors for maintenance of hematopoiesis 13, 31 .
Besides the tightly coupled relationship between the osteoblast and the osteoclast, the direct role of the osteoclast in the regulation of the fully developed hematopoietic niche in the adult animal is still controversial and remains to be fully clarified.
One approach used to investigate the role of osteoclasts for hematopoiesis has been to inhibit these cells pharmacologically with bisphosphonates. A recent publication by Lymperi and coworkers showed that when osteoclast function was blocked by injecting mice with bisphosphonate alendronate, HSC number was reduced 23 . However, another report stated that administration of the same compound resulted in expansion of HSCs and in an up-regulated mobilization of these cells to the circulation in response to G-CSF
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. A third group reported that the bisphosphonate zolendronic acid did not affect HSC number even though it induced osteopetrosis 32 . Thus, this experimental approach has yielded contrasting results.
Another way to delineate the role of osteoclasts for hematopoiesis has been to examine the hematopoietic compartment in different mouse models of osteopetrosis, a group of diseases characterized by either a lack of osteoclasts or by osteoclasts with a defective function.
Analyzing three such models, the op/op, c-Fos-deficient and RANKL (receptor activator of nuclear factor kappa B ligand) deficient mice Miyamoto and co-workers reached the conclusion that osteoclasts are dispensable for hematopoietic stem cell maintenance and characterized by an increased number of osteoclasts that lack resorptive capacity. They found that osteoclasts are required for formation of the HSC niche via the induction of osteoblastic development.
The aim of the present study was to determine whether osteoclasts and/or the osteoclast resorptive function are required for the maintenance and function of HSCs in fully developed adult mice. To avoid the use of pharmacological agents and their potential off-target effects,
we, like Miyamoto and co-workers, employed two murine models of osteopetrosis, the osteoclast-rich oc/oc strain mentioned above and RANK KO mice that are devoid of osteoclasts. As these mice die well before adulthood we elected to establish chimeric adult animals by transplanting fetal liver HSCs from the respective osteopetrotic strain to adult wild type mice.
Both oc/oc and RANK KO recipients developed a mild osteopetrotic phenotype, similar to that found in a recent study using the oc/oc recipient model 28 . As analyzed both in vitro and in vivo the oc/oc recipients exhibited an increased number of osteoclasts, whereas the RANK KO recipients developed a severe reduction of osteoclasts, as was expected and consistent with the original phenotypes having increased number or no osteoclasts respectively 24, 25 . The bone resorption marker CTX-I was equally reduced in both recipient groups, and significant and similar increases in femoral cortical bone volume fraction and cortical thickness was observed in both mouse models. This is also in line with previously published data 28 .
When analyzing the hematopoietic phenotype of the transplanted recipients, bone marrow cellularity was unchanged and comparable to control recipients in both experimental groups. decrease in phenotypic HSCs was relatively small and we regard the results from the competitive secondary repopulation analysis as more important than the FACS data in terms of assessing the stem cell compartment in the primary transplant recipients.
In terms of explaining the differences between our findings and the previously mentioned findings by Lymperi et al. 23 , several things stand out. First of all, the degree of suppression of resorption is difficult to compare, as measurement of a resorption marker was included only in our study. When looking at the suppression of TRAP 5b, it appears that the in vivo reduction in osteoclast number in the RANK KO recipient group of our study was a little larger than observed in the alendronate treated mice (50% compared to approximately 30%). In terms of bone volume changes these are not directly comparable due to differences in the bone compartment assessed, the length of the intervention, and the age of the mice, where we transplanted mice older than 12 weeks and followed them for another 15 In summary in the present study we investigated how a reduction in osteoclasts or the abolishment of the osteoclast resorptive function affect HSCs and the maintenance of hematopoiesis in adult mice that were followed for more than 3 months after establishment of hematopoiesis derived from two different osteopetrotic mouse strains. Overall the changes seen in the hematopoietic compartment were minimal even though the mice in both models developed mild osteopetrotic phenotypes. Most importantly, we found that the HSC function as determined in a secondary competitive transplantation setting in both oc/oc and RANK KO recipients was comparable to that of control recipients. Thus, the conclusion from our experiments is that osteoclasts appear not to be crucial for stem cell maintenance and function in adult mice. 
Micro Computed Tomography (µCT)
The cortical and trabecular femoral bone architecture was evaluated using a high resolution µCT scanner (µCT 35; Scanco Medical AG, Brüttisellen, Switzerland). A 232 slices (1392 µm) high region at the mid-femoral diaphysis was scanned in high-resolution mode (1000 projections/180°) with a spatial resolution of 6 µm × 6 µm × 6 µm, an X-ray tube voltage of 55 kVp and current of 145 µA, and an integration time of 600 ms. The 3D data sets were lowpass-filtered using a Gaussian filter (σ = 0.8, support = 1) and segmented with a fixed threshold filter (628.8 mg HA/cm 3 ).
Splenocyte osteoclast differentiation and resorption
Isolated spleen cells were differentiated into mature osteoclasts on either bovine bone slices 
